2nd annual Faces of Glaucoma campaign unveiled by Bausch + Lomb, Glaucoma Research Foundation

News
Article

The campaign will spotlight educational resources and share stories of individuals and families living with glaucoma to raise awareness and encourage proactive eye health management.

faces of glaucoma campaign kicked off by Bausch + Lomb and The Glaucoma Research Foundation - Image credit: Adobe Stock / ©pikselstock

Image credit: Adobe Stock / ©pikselstock

Bausch + Lomb and Glaucoma Research Foundation have partnered to launch the second annual Faces of Glaucoma campaign. The campaign, aimed at highlighting diverse patient stories and raising awareness of glaucoma will take place throughout Glaucoma Awareness Month in January.

Throughout the month, Bausch + Lomb and GRF will spotlight educational resources and share stories of individuals and families living with glaucoma to raise awareness and encourage proactive eye health management. In addition, B+L will support a fundraising campaign, matching up to $20,000, which will support GRF research on a potential cure for glaucoma.

The search for a cure for glaucoma is led by Catalyst for a Cure, Glaucoma Research Foundation’s flagship research program. According to the organization, the Catalyst for a Cure initiative brings together neuroscientists and glaucoma specialists to study glaucoma, find better treatments, and accelerate progress toward vision restoration and a cure.

Materials from the campaign are available online and include information on lifestyle tips for glaucoma patients as well as what can be done to prevent glaucoma.

Andrew Stewart, president of global pharmaceuticals and international consumer, Bausch + Lomb discussed the initiative in a press release from the company.

“It’s estimated that half of people with glaucoma don’t know that they have it, demonstrating a need for continuing education and awareness efforts,” said Stewart. “In collaboration with Glaucoma Research Foundation, we aim to encourage people to take an active role in understanding and managing their risk, starting with seeing an eye doctor.”

Early detection being key, the organizations state that glaucoma checkups should be conducted:

  • before age 40, every two to four years
  • from age 40 to age 54, every one to three years
  • from age 55 to 64, every one to two years
  • after age 65, every six to 12 months
References:
  1. Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual “Faces of Glaucoma” Campaign and Fundraising Challenge. Press Release. Published January 7, 2025. Accessed January 7, 2025.https://www.businesswire.com/news/home/20250107193963/en/Bausch-Lomb-and-Glaucoma-Research-Foundation-Launch-Second-Annual-%E2%80%9CFaces-of-Glaucoma%E2%80%9D-Campaign-and-Fundraising-Challenge
Recent Videos
Dr. Nate Lighthizer shares key takeaways from the SECO Showcase on anterior segment technology and full laser certification course offered at SECO.
Shan Lin, MD, and John Berdahl, MD, share their perspectives as ophthalmologists regarding the importance of comanagement.
Robert L. Stamper, MD, overviews his optometric track talk titled Objective Perimetry - Can you see it? at this year's Glaucoma 360 meeting.
Yvonne Ou, MD, outlined lifestyle modifications for glaucoma management that have proven beneficial, including yoga and cycling.
Robert L. Stamper, MD, weighs in on what he think more optometrists should know about glaucoma and current misconceptions concerning glaucoma testing.
John Berdahl, MD, overviews the new FYXS Ocular Pressure Adjusting Pump and HERCULES trial at the Glaucoma 360 meeting.
Shan Lin, MD, outlines a new generation of minimally invasive glaucoma surgeries (MIGS) at Glaucoma 360.
Danica Marrelli, OD, FAAO, at Glaucoma 360 discussing visual field testing for patients with glaucoma
Sherrol Reynolds, OD, FAAO, values the ophthalmic-optometric collaboration on display at the summit, running from February 14-17, 2025 in San Juan, Puerto Rico.
© 2025 MJH Life Sciences

All rights reserved.